[null, {"document_url": "https://sginvestors.io/sgx/stock/t14-tianjin-zx-usd/blog-article", "unformatted_src": "https://2.bp.blogspot.com/-m5179P4e-YQ/WBnkjRhkirI/AAAAAAAAHIo/CFTwmn8YoEQ-5Owi8gmKHI9xCMqq3QTiQCLcB/s1600/TianjinZhongxin%2BPharma.png", "src": "https://2.bp.blogspot.com/-m5179P4e-YQ/WBnkjRhkirI/AAAAAAAAHIo/CFTwmn8YoEQ-5Owi8gmKHI9xCMqq3QTiQCLcB/s1600/TianjinZhongxin%2BPharma.png", "formatted_filename": "TianjinZhongxin BPharma"}, null, {"document_url": "https://sginvestors.io/sgx/stock/t14-tianjin-zx-usd/blog-article", "unformatted_src": "https://lh3.googleusercontent.com/-lqYm7TlMSjo/Veye4pTHhQI/AAAAAAAAB58/m9qG7y0Y5lo/s800-Ic42/blogger%252520says.png", "src": "https://lh3.googleusercontent.com/-lqYm7TlMSjo/Veye4pTHhQI/AAAAAAAAB58/m9qG7y0Y5lo/s800-Ic42/blogger%252520says.png", "formatted_filename": "blogger says"}, null, {"document_url": "https://sginvestors.io/sgx/stock/t14-tianjin-zx-usd/blog-article", "unformatted_src": "https://lh3.googleusercontent.com/-zAswBSCv-r8/VYLx7puxX_I/AAAAAAAAAtQ/bjN6RDxj2iU/s800/motleyfool.png", "src": "https://lh3.googleusercontent.com/-zAswBSCv-r8/VYLx7puxX_I/AAAAAAAAAtQ/bjN6RDxj2iU/s800/motleyfool.png", "formatted_filename": "motleyfool"}, null]
SGinvestors.io > SGX Listed Stock > TIANJIN ZHONG XIN PHARM GROUP (SGX:T14) > Bloggers Say
 USD 0.930
+0.010 / +1.09%
Share Price as of: 2018-10-24 13:49
Market / ISIN Code: SGX Mainboard / CNE100000924
GICS® Sector / Industry Group / Industry: Health Care / Pharmaceuticals, Biotechnology & Life Sciences / Pharmaceuticals

Tianjin Zhongxin Pharmaceutical Blogger ArticlesTIANJIN ZHONG XIN PHARM GROUP Blogger Articles SGX Listed TIANJIN ZHONG XIN PHARM GROUP (SGX:T14) Blogger Articles T14.SI Blogger Articles Sim Kang Heong
4 Stocks This Week (Healthcare) [5 October 2018] – Raffles Medical; Tianjin Zhongxin Pharma; Parkway Life; First REIT
The healthcare sector has traditionally been considered as a defensive segment with good multi-year growth potential, in step with an ageing societal demographic, rising affluence and the continued demand from medical tourism. Continued market volatility and rising US-China trade tensions has also benefitted defensive sectors like healthcare, which has seen inflows from institutional funds recently. Tracking the performance of healthcare stocks listed on the Singapore Exchange is the iEdge SG All Healthcare Index, a f index that comprises 31 constituents. The five best-yielding constituents of the iEdge SG All Healthcare Index are: First REIT (6.9%), ISEC Healthcare (4.9%), Singapore O&G (4.9%), Parkway Life REIT (4.8%), and Talkmed Group (3.4%). These five stocks have average